4
Changes in Ownership
IRulya Therapeutics Inc. Filed Acc 0001209191-23-006402
Options or other derivatives
- Chief Executive Officer acquired 600,000 shares (grant or award)
From the SEC's structured data for this filing
IRulya Therapeutics Inc. Filed Acc 0001209191-23-006402
Options or other derivatives
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…